View Older Stories View More Recent Stories

Jan 17, 2017 09:31AM Precision Oncology Diagnostics Leader, Cancer Genetics, Inc. & Precision Therapeutics Company, Lantern Pharma, Inc. Announce Strategic Collaboration Focused on Drug Rescue & Repurposing Levera
Jan 9, 2017 09:30AM Cancer Genetics (CGIX) Reports Multiple Agreements, Collaborations for Liquid Biopsy Programs
Jan 9, 2017 09:27AM Cancer Genetics, Inc. Announces Multiple Agreements & Collaborations to Develop Liquid Biopsy Programs with Leading Biopharma Companies
Dec 7, 2016 07:54AM Cancer Genetics, Inc. Is Selected by BeiGene, Ltd. to Collaborate on Clinical Trial Services & Advance Portfolio of Novel Oncology Therapeutics
Dec 5, 2016 08:17AM Merck (MRK) Lists Cancer Genetics (CGIX) as KEYTRUDA National Reference Laboratory
Dec 5, 2016 08:15AM Cancer Genetics, Inc. Listed by Merck as a National Reference Laboratory for KEYTRUDA® (pembrolizumab) Companion Diagnostic Testing
Dec 1, 2016 09:21AM Cancer Genetics, Inc. and Leading Collaborators to Present Innovative Insights That Will Advance Precision Medicine in Diffuse Large B-cell Lymphoma (DLBCL) at American Society of Hematology (ASH) Ann
Nov 10, 2016 07:00AM Cancer Genetics, Inc. Announces Strong Third Quarter with 68% Year Over Year Revenue Growth and Highlights Path to Future Profitability
Nov 3, 2016 07:00AM Cancer Genetics, Inc. to Report Third Quarter 2016 Financial Results and Host Conference Call on Thursday, November 10, 2016
Nov 2, 2016 07:21AM Cancer Genetics (CGIX) Announces Launch of Focus::Renal
Nov 2, 2016 07:00AM Cancer Genetics, Inc. Launches Focus::Renal™, a Unique, Comprehensive and Highly Sensitive Next Generation Sequencing (NGS) Panel for Enabling Precision and Personalized Medicine in Renal Cancers
Oct 14, 2016 04:01PM Cancer Genetics, Inc. to Present at the Dawson James Securities Growth Stock Conference on October 20
Sep 26, 2016 09:29AM Pre-Open Stock Movers 09/26: (ARRY) (CHMT) (GWPH) Higher; (PTIE) (DRRX) (SALE) Lower (more...)
Sep 26, 2016 07:33AM Cancer Genetics (CGIX), ApoCell Enter Strategic Partnership for Circulating Tumor Cells
Sep 26, 2016 07:32AM Cancer Genetics, Inc. and ApoCell Announce Partnership Focused on Transforming Cancer Profiling & Therapy Selection Leveraging Proprietary, High-Performance, Liquid Biopsy Platform for Rare Cell C
Sep 21, 2016 07:30AM Cancer Genetics, Inc. to Present at Two Upcoming Investor Conferences During September
Sep 20, 2016 07:31AM Cancer Genetics (CGIX), BARC Enter Partnership for Clinical Trials
Sep 20, 2016 07:30AM Cancer Genetics, Inc. Announces a Global Partnership with BARC Global Central Laboratory to Offer Comprehensive Clinical Trial and Companion Diagnostic Solutions for the Oncology Industry
Sep 9, 2016 07:33AM Cancer Genetics (CGIX) Enters 2.75M Share Registered Direct Offering
Sep 9, 2016 07:30AM Cancer Genetics Announces $5.5 Million Registered Direct Offering
Sep 8, 2016 04:43PM Cancer Genetics, Inc. to Present at the Rodman & Renshaw 18th Annual Global Investment Conference
Aug 17, 2016 07:32AM Cancer Genetics' (CGIX) Focus::Myeloid NGS-Based Panel Receives Approval in New York State
Aug 17, 2016 07:30AM Cancer Genetics, Inc. Strengthens Position as a Leader in Myeloid Cancer Diagnosis and Management Receiving New York State Approval for Focus::Myeloid™, a Targeted NGS Panel for Improved Diagnosis,
Aug 1, 2016 05:00PM Cancer Genetics to Report Second Quarter Earnings on Wednesday, August 10
Jul 18, 2016 09:30AM Cancer Genetics Inc. Selected by H3 Biomedicine Inc., to Provide Biomarker Discovery and Testing for a Global Drug Development Program in Hematologic Cancers
Jun 30, 2016 07:32AM Cancer Genetics' (CGIX) Focus::CLL Approved in New York State
Jun 30, 2016 07:30AM Cancer Genetics, Inc. Receives New York State Approval for Focus::CLL™, a Unique NGS Panel for Chronic Lymphocytic Leukemia, Reinforcing the Company’s Market-Leading Position in the Diagnosis and
Jun 29, 2016 07:59AM Cancer Genetics (CGIX) Begins Offering VENTANA PD-L1 as Complimentary IHC Test for TECENTRIQ
Jun 29, 2016 07:58AM Cancer Genetics, Inc. Expands Its Immuno-Oncology Franchise With The Addition of The FDA-Approved VENTANA PD-L1 (SP142) Assay As A Complementary Diagnostic Test For TECENTRIQ™
Jun 27, 2016 07:30AM Cancer Genetics Names Healthcare Technology Industry Veteran John Jay Roberts as COO and Executive Vice President of Finance
Jun 23, 2016 08:26AM Cancer Genetics (CGIX) Enters Distribution Agreement for TOO Test in India, South Asia
Jun 23, 2016 08:25AM Cancer Genetics, Inc. and Sayre Therapeutics Announce Distribution Agreement to Commercialize CGI’s Proprietary FDA-cleared Tissue of Origin (TOO®) Test Throughout India and South Asia
Jun 7, 2016 07:30AM Cancer Genetics, Inc. to Present at the 2016 LD Micro Invitational Investor Conference
Jun 6, 2016 08:00AM HTG Molecular Diagnostics and Cancer Genetics Announce Presentation of an Immuno-Oncology Study at the American Society of Clinical Oncology (ASCO) 2016 Annual Meeting
May 17, 2016 07:30AM Cancer Genetics, Inc. Launches The Most Comprehensive & Clinically Actionable Next Generation Sequencing Panel in Precision Medicine, FOCUS::Lymphoma ™
May 10, 2016 04:01PM Cancer Genetics, Inc. Announces 39% Revenue Increase and Provides Recent Company Highlights
May 5, 2016 07:14AM Cancer Genetics, Inc. to Present at Pioneers 2016 Conference Presented by Joseph Gunnar & Co., LLC
May 4, 2016 09:30AM Cancer Genetics (CGIX) Actively Testing, Providing Data for 12 IO Clinical Trials, 3 Academic Collaborations
May 4, 2016 08:35AM Cancer Genetics, Inc. Significantly Expands Marketshare In Immuno-Oncology Focused Clinical Trials With 12 Active Clinical Trials In Progress With Leading Biotech and Pharma Companies
May 3, 2016 07:36PM Cancer Genetics to Report First Quarter 2016 Financial Results on Tuesday, May 10th
Mar 14, 2016 07:30AM Cancer Genetics, Inc. to Present at 28th Annual ROTH Conference on March 16, 2016
Mar 10, 2016 03:53PM Cancer Genetics, Inc. Announces Strong Fourth Quarter and Full-Year 2015 Results and Provides 2016 Business Update
Mar 7, 2016 09:37AM Cancer Genetics, Inc. Launches Next Generation Sequencing Panel for Diagnosis & Treatment Selection in Solid Tumors, CGI FOCUS::Oncomine™
Mar 3, 2016 07:30AM Cancer Genetics to Report Fourth Quarter & Fiscal 2015 Financial Results on Thursday, March 10
Feb 8, 2016 09:21AM Cancer Genetics, Inc. to Present at Source Capital Group’s 2016 Disruptive Growth & Healthcare Conference
Feb 5, 2016 08:09AM Cancer Genetics (CGIX) Enters in-Network Provider Agreement with BCBS of Minnesota
Feb 5, 2016 08:00AM Cancer Genetics, Inc. Expands the Reach of Precision Medicine by Over 2.6 Million Individuals as it Signs a New Agreement With Blue Cross Blue Shield of Minnesota
Jan 21, 2016 08:00AM Cancer Genetics Launches Comprehensive Immuno-Oncology Testing Portfolio For Use in Clinical Trials, Translational Research, and Therapy Selection for Patients
Jan 6, 2016 06:23PM Cancer Genetics, Inc. (CGI) to Present Results of Collaborative Renal Biopsy and Clear Cell Renal Cell Carcinoma (ccRCC) Studies at the 2016 Genitourinary Cancer Symposium
Nov 24, 2015 08:00AM Cancer Genetics, Inc. to Present at Piper Jaffray 27th Annual Healthcare Conference on December 2nd
View More Recent Stories View Older Stories